101 results
6-K
EX-3.1
GMVDF
G Medical Innovations Holdings Ltd.
18 Dec 23
Report of Foreign Private Issuer
4:39pm
undertaking if the parent undertaking (i) holds a majority of the voting rights in it, or (ii) is a member of it and has the right to appoint or remove … , a majority of the voting rights in it;
“Treasury Shares”
means Shares held in treasury pursuant to the Companies Act and these Articles;
“uncertificated
6-K
EX-99.2
GMVDF
G Medical Innovations Holdings Ltd.
29 Nov 23
Notice of Extraordinary General Meeting
12:00am
; OUTSTANDING VOTING SECURITIES; VOTING RIGHTS
Only Shareholders of record at the close of business on 22 November 2023 will be entitled to notice …
As at the date of the Notice, the Company has 200,489 Preferred Shares and 277,763 Ordinary Shares in issue (excluding 81 treasury shares with no voting rights
6-K
EX-99.2
GMVDF
G Medical Innovations Holdings Ltd.
25 Aug 23
Notice of Annual General Meeting
4:20pm
firms and others for forwarding material to the beneficial owners of shares.
RECORD DATE; OUTSTANDING VOTING SECURITIES; VOTING RIGHTS
Only … issued to Dr. Geva and including 5,699 treasury shares with no voting rights) and the authorized share capital of the Company is US$10,000 divided
F-1
GMVDF
G Medical Innovations Holdings Ltd.
27 Jul 23
Registration statement (foreign)
4:47pm
in this offering do not confer any rights of Ordinary Share ownership on their holders, such as voting rights, but rather merely represent the right to acquire … confirming such reduction. See “Voting Rights and Thresholds” below.
Share Repurchase
Subject to Nasdaq Stock Market Rules, the Cayman Islands
S-8
EX-99.1
GMVDF
G Medical Innovations Holdings Ltd.
5 Jul 23
Registration of securities for employees
7:37am
of the Global Equity Incentive Plan.
Shareholder Rights. a Participant shall not be entitled to receive dividends, exercise voting rights, or exercise any other … voting rights, or exercise any other rights of a shareholder with respect to RSUs until the RSUs have Vested and been exercised, and the Shares
424B4
sqv0f8nqi kss
4 Apr 23
Prospectus supplement with pricing info
12:13pm
6-K
EX-99.1
akeunw1ssva
16 Dec 22
Notice of Extraordinary General Meeting
5:15pm
6-K
EX-99.1
dhvbp6eq45f
18 Nov 22
Report of Foreign Private Issuer
12:34pm
6-K
EX-99.1
0czf79xnl 5b
9 Nov 22
Notice of Extraordinary General Meeting
2:05pm
6-K
EX-99.1
b2n837
31 Oct 22
Notice of Extraordinary General Meeting
6:16pm
6-K
EX-99.3
dcy rhejyjvse9
27 Oct 22
Securities Purchase Agreement
4:44pm
6-K
EX-99.3
1jg56zywv zv
18 Jul 22
Report of Foreign Private Issuer
9:43am
POS AM
z0yncs8ia t04
13 Jul 22
Prospectus update (post-effective amendment)
1:05pm
POS AM
wok 0atabkhxec
13 Jul 22
Prospectus update (post-effective amendment)
1:03pm
6-K
EX-99.2
e1flstqkihg
17 Jun 22
Notice of Annual General Meeting
9:06am
F-1
78pq7637e xwkcw339sj
19 May 22
Registration statement (foreign)
5:21pm
20-F
EX-2.1
waq1p1 5c
29 Apr 22
Annual report (foreign)
12:00am
6-K
EX-99.3
3sxcgdglg6ou2wf61
21 Apr 22
G Medical Innovations Holdings Ltd Announces Closing of $8 Million Private Placement
4:01pm
6-K
EX-99.7
ok5ryeztfchzsikkjxhk
18 Apr 22
Report of Foreign Private Issuer
5:07pm